The University of Chicago Header Logo

Azhar M. Awan

Concepts (128)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
13
2004
1721
0.300
Why?
Prostate-Specific Antigen
6
2004
353
0.250
Why?
Head and Neck Neoplasms
6
1991
1052
0.120
Why?
Radioimmunodetection
2
2004
13
0.120
Why?
Unrelated Donors
1
2014
50
0.120
Why?
Peripheral Blood Stem Cell Transplantation
1
2014
67
0.120
Why?
Radiotherapy, Conformal
3
2002
83
0.110
Why?
Transplantation Conditioning
1
2014
373
0.110
Why?
Radiation Injuries
2
2004
156
0.100
Why?
Hematologic Neoplasms
1
2014
329
0.100
Why?
Radiotherapy Dosage
9
2002
468
0.100
Why?
Radiotherapy
5
2004
328
0.090
Why?
Palliative Care
1
1990
257
0.080
Why?
Combined Modality Therapy
11
1999
1686
0.080
Why?
Hematopoietic Stem Cell Transplantation
1
2014
878
0.080
Why?
Risk Assessment
2
2004
2264
0.070
Why?
Radiotherapy Planning, Computer-Assisted
3
2004
176
0.070
Why?
Neoplasm Recurrence, Local
4
2004
1313
0.070
Why?
Postoperative Care
2
2004
221
0.070
Why?
Male Urogenital Diseases
2
2004
9
0.070
Why?
Sarcoma
3
1995
215
0.070
Why?
Adenocarcinoma
3
2002
1169
0.060
Why?
Decision Making, Computer-Assisted
1
2004
12
0.060
Why?
Gastrointestinal Diseases
2
2004
146
0.060
Why?
Antineoplastic Agents, Hormonal
1
2004
150
0.060
Why?
Carcinoma, Non-Small-Cell Lung
2
1991
1075
0.050
Why?
Lung Neoplasms
3
1993
2262
0.050
Why?
Radiotherapy, High-Energy
4
1999
49
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
6
1993
2438
0.050
Why?
Male
20
2014
40984
0.050
Why?
Humans
27
2014
86657
0.040
Why?
Radiation Tolerance
2
1990
168
0.040
Why?
Aged
13
2014
18422
0.040
Why?
Middle Aged
15
2014
25036
0.040
Why?
Androgen Antagonists
1
1999
144
0.040
Why?
Urinary Bladder Neoplasms
2
1993
383
0.040
Why?
Aged, 80 and over
9
2004
6513
0.040
Why?
Penile Erection
1
1997
22
0.040
Why?
Patient Selection
1
2000
686
0.040
Why?
Socioeconomic Factors
2
2002
567
0.030
Why?
Clinical Trials as Topic
1
2000
1169
0.030
Why?
Neoplasm Staging
3
2001
1938
0.030
Why?
Prostatectomy
3
2004
471
0.030
Why?
Myeloablative Agonists
1
2014
34
0.030
Why?
Busulfan
1
2014
39
0.030
Why?
Whole-Body Irradiation
1
2014
63
0.030
Why?
Follow-Up Studies
5
2002
3642
0.030
Why?
Extremities
1
1995
167
0.030
Why?
Allografts
1
2014
172
0.030
Why?
Disease-Free Survival
3
2004
1204
0.030
Why?
Erythropoietin
1
1993
91
0.030
Why?
Fluorouracil
3
1989
556
0.030
Why?
Carcinoma, Squamous Cell
2
1990
1077
0.030
Why?
Anemia
1
1993
128
0.030
Why?
Hydroxyurea
2
1989
239
0.030
Why?
Intraoperative Period
1
1991
90
0.030
Why?
Prognosis
4
2004
3680
0.030
Why?
Radiotherapy, Computer-Assisted
2
2004
25
0.020
Why?
Carcinoma, Transitional Cell
1
1993
164
0.020
Why?
Spinal Cord Compression
1
1990
27
0.020
Why?
Superior Vena Cava Syndrome
1
1990
16
0.020
Why?
Cranial Irradiation
1
1990
36
0.020
Why?
Bone Neoplasms
2
1990
321
0.020
Why?
Cell Survival
2
1990
969
0.020
Why?
Brachytherapy
1
1990
119
0.020
Why?
Neoadjuvant Therapy
2
2004
318
0.020
Why?
Breast Neoplasms
3
1993
2903
0.020
Why?
Actuarial Analysis
2
2001
66
0.020
Why?
Laser Therapy
1
1990
142
0.020
Why?
Analysis of Variance
2
2001
911
0.020
Why?
Retrospective Studies
4
2004
8495
0.020
Why?
Chicago
2
2002
1380
0.020
Why?
Methotrexate
3
1993
249
0.020
Why?
Carcinoma
1
1989
436
0.020
Why?
Adult
6
2014
25657
0.020
Why?
Brain Neoplasms
1
1990
763
0.020
Why?
Female
9
2014
44547
0.020
Why?
Liver Neoplasms
1
1990
736
0.020
Why?
Cisplatin
3
1993
612
0.020
Why?
Vinblastine
2
1993
108
0.010
Why?
Tomography, X-Ray Computed
1
1991
2587
0.010
Why?
Doxorubicin
2
1993
295
0.010
Why?
Newspapers as Topic
1
2000
6
0.010
Why?
Television
1
2000
29
0.010
Why?
Comorbidity
1
2004
944
0.010
Why?
Survival Analysis
1
2004
1538
0.010
Why?
Chemoprevention
1
2000
91
0.010
Why?
Sensitivity and Specificity
1
2004
1991
0.010
Why?
Dose-Response Relationship, Radiation
1
1999
188
0.010
Why?
Practice Patterns, Physicians'
1
2004
584
0.010
Why?
In Vitro Techniques
2
1990
989
0.010
Why?
Cohort Studies
1
2004
2768
0.010
Why?
Neoplasms
1
1991
2898
0.010
Why?
Erectile Dysfunction
1
1997
73
0.010
Why?
Severity of Illness Index
1
2002
1802
0.010
Why?
Probability
1
1997
355
0.010
Why?
Radiobiology
1
1995
13
0.010
Why?
Regression Analysis
1
1997
596
0.010
Why?
Cell Line
2
1990
2469
0.010
Why?
Treatment Failure
1
1995
286
0.010
Why?
Radiotherapy, Adjuvant
1
1995
292
0.010
Why?
Treatment Outcome
2
1999
7998
0.010
Why?
Injections, Subcutaneous
1
1993
117
0.010
Why?
Cystectomy
1
1993
102
0.010
Why?
United States
1
2004
6681
0.010
Why?
Recombinant Proteins
1
1993
1015
0.010
Why?
Clinical Protocols
1
1991
156
0.010
Why?
Quality of Life
1
1999
1585
0.010
Why?
Acute Disease
1
1993
826
0.010
Why?
Pilot Projects
1
1993
840
0.010
Why?
Risk Factors
1
2001
5420
0.010
Why?
Esthetics
1
1989
44
0.010
Why?
Stomatitis
1
1989
30
0.010
Why?
Drug Evaluation
1
1989
141
0.010
Why?
Adolescent
2
1995
8984
0.010
Why?
Remission Induction
1
1991
722
0.010
Why?
Mastectomy, Segmental
1
1989
93
0.010
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1989
113
0.010
Why?
Sarcoma, Ewing
1
1988
42
0.010
Why?
Lymph Node Excision
1
1989
217
0.000
Why?
Soft Tissue Neoplasms
1
1988
126
0.000
Why?
Bone Marrow
1
1989
435
0.000
Why?
Osteosarcoma
1
1988
158
0.000
Why?
Drug Administration Schedule
1
1988
916
0.000
Why?
Survival Rate
1
1989
1864
0.000
Why?
Prospective Studies
1
1993
4215
0.000
Why?
Time Factors
1
1993
5211
0.000
Why?
Antineoplastic Agents
1
1991
2360
0.000
Why?
Awan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_